Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Chemical Communications (Cambridge, England)|December 5, 2025
Design, synthesis and biological activity of potential retrometabolic polymyxins via thiol-ene chemistryCatherine Smith, Andrew Siow, Renata Kowalczyk, et al.
Journal of Natural Products|February 29, 2024
Synthesis, Structure-Activity Relationship Study, Bioactivity, and Nephrotoxicity Evaluation of the Proposed Structure of the Cyclic Lipodepsipeptide Brevicidine BDennise Palpal-Latoc, Aimee J Horsfall, Alan J Cameron, et al.
JCI Insight|January 23, 2025
Permanent defects in renal medullary structure and function after reversal of urinary obstructionThitinee Vanichapol, Alex Gonzalez, Rachel Delgado, et al.
ACS Pharmacology & Translational Science|April 18, 2022
Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney InjuryKeith Long, Zoe Vaughn, Michael David McDaniels, et al.
The Journal of Biological Chemistry|September 5, 2020
SOX9 promotes stress-responsive transcription of VGF nerve growth factor inducible gene in renal tubular epithelial cellsJi Young Kim, Yuntao Bai, Laura A Jayne, et al.
Journal of the Royal Society of New Zealand|October 23, 2024
Derivation of induced pluripotent stem cell lines from New Zealand donorsJin Kyo Oh, Aneta Przepiorski, Hao-Han Chang, et al.
Nature Reviews. Nephrology|February 17, 2022
Experimental models of acute kidney injury for translational researchNeil A Hukriede, Danielle E Soranno, Veronika Sander, et al.
Angewandte Chemie (International Ed. in English)|June 27, 2024
Allenamides as a Powerful Tool to Incorporate Diversity: Thia-Michael Lipidation of Semisynthetic Peptides and Access to β-Keto AmidesTae-Ung Na, Veronika Sander, Alan J Davidson, et al.
Kidney International|September 17, 2021
Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibitionYuntao Bai, Ji Young Kim, Bijay Bisunke, et al.
RSC Medicinal Chemistry|February 18, 2026
Introducing CLipPA lipid chemodiversity to enzymatically truncated polymyxin B: a soft drug strategy to combat Gram-negative pathogensTae-Ung Na, Yann O Hermant, Andrew Siow, et al.
Pageof 4